Sprim

Executive Summary

Sprim is a France-based life science consulting and innovation firm that uniquely combines a global consulting agency (SPRIM Health Group) with an investment arm (SPRIM Global Investments). Founded in 2008, the company operates as a hybrid entity, leveraging deep expertise in strategy, regulatory affairs, clinical research, and medical marketing to create, validate, and commercialize health-focused products and brands across healthcare, food, and nutrition sectors. With its integrated model, Sprim aims to bridge the gap between scientific innovation and market success, serving both established corporations and emerging ventures. The company's focus on digital health and AI/ML positions it well to capitalize on the growing convergence of technology and life sciences. Despite limited publicly available financial data, Sprim's longevity and diversified business model suggest a stable foundation with potential for growth as it expands its portfolio of proprietary products and services.

Upcoming Catalysts (preview)

• TBDLaunch of proprietary digital health product or platform50% success
• TBDStrategic partnership with a major pharmaceutical or nutrition company60% success
• TBDExpansion of investment arm into new therapeutic areas40% success